OPTIMAL CUT-OFF POINT FOR ELECTROCARDIOGRAM IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ON HYDROXYCHLOROQUINE THERAPY

被引：0
|
作者：
Herrero-Morant, A. [1 ]
Zubiaur-Zamacola, J. [1 ]
Margarida-de Castro, A. [1 ]
Perez-Barquin, R. [1 ]
Blanco, R. [1 ]
机构：
[1] Marques Valdecilla Univ Hosp, Rheumatol & Cardiol, Santander, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Disease-modifying drug (DMARDs); Systemic lupus erythematosus;
D O I：
10.1136/annrheumdis-2023-eular.4462
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1148
引用
收藏
页码：904 / 904
页数：1
相关论文
共 50 条
  • [41] QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine
    Nishiyama, Taihei
    Kondo, Yuya
    Tsuboi, Hiroto
    Noma, Hisashi
    Tabuchi, Daiki
    Sugita, Toshiki
    Okamoto, Shota
    Terasaki, Toshihiko
    Shimizu, Masaru
    Honda, Fumika
    Ohyama, Ayako
    Kurata, Izumi
    Yagishita, Mizuki
    Abe, Saori
    Takahashi, Hiroyuki
    Osada, Atsumu
    Hagiwara, Shinya
    Matsumoto, Isao
    Sumida, Takayuki
    MODERN RHEUMATOLOGY, 2021, 31 (06) : 1107 - 1112
  • [42] The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine
    Sakai, Ryoko
    Honda, Suguru
    Tanaka, Eiichi
    Majima, Masako
    Konda, Naoko
    Takada, Hideto
    Harigai, Masayoshi
    LUPUS, 2020, 29 (13) : 1712 - 1718
  • [43] Pharmacokinetics of hydroxychloroquine in Japanese systemic lupus erythematosus patients with renal impairment
    Shimizu, Mikiko
    Furudate, Sumito
    Nagai, Yoshiki
    Shimada, Kota
    Ohshima, Miho
    Setoguchi, Keigo
    Hashiguchi, Masayuki
    Yokogawa, Naoto
    MODERN RHEUMATOLOGY, 2023, 33 (05) : 953 - 960
  • [44] Factors Related to Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus
    Lee, Ji Yeon
    Lee, Jennifer
    Kwok, Seung-Ki
    Ju, Ji Hyeon
    Park, Kyung-Su
    Park, Sung-Hwan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] Is it necessary to monitor blood hydroxychloroquine concentrations in patients with systemic lupus erythematosus?
    Costedoat-Chalumeau, N.
    Amoura, Z.
    Hulot, J. -S.
    Lechat, P.
    Piette, J. -C.
    REVUE DE MEDECINE INTERNE, 2006, 27 (09): : 655 - 657
  • [46] Antidiabetic effects of hydroxychloroquine in two Japanese patients with systemic lupus erythematosus
    Shunichiro Hanai
    Yoshiaki Kobayashi
    Masashi Ichijo
    Ryosuke Ito
    Kei Kobayashi
    Daiki Nakagomi
    Diabetology International, 2022, 13 : 447 - 451
  • [47] Pharmacokinefic-pharmacodynamic relationship of hydroxychloroquine in patients with systemic lupus erythematosus
    Hulot, Jean-Sebastien
    Costedoat-Chalumeau, Nathalie
    Amoura, Zahir
    Aymard, Guy
    Musset, Lucille
    Piette, Jean-Charles
    Lechat, Philippe
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 482 - 482
  • [48] Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients
    Polanski, Jose F.
    Tanaka, Eloise A.
    Barros, Harymy
    Chuchene, Adriana G.
    Miguel, Patricia T. G.
    Skare, Thelma L.
    LARYNGOSCOPE, 2021, 131 (03): : E957 - E960
  • [49] Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine
    Baalbaki, Sima
    Szychowski, Jeff M.
    Tang, Ying
    Wetta, Luisa
    Subramaniam, Akila
    OCHSNER JOURNAL, 2020, 20 (04): : 362 - 367
  • [50] Hydroxychloroquine lowers the risk for Diabetes Mellitus in patients with Systemic Lupus Erythematosus
    Levinson, Dennis
    Abugroun, Ashraf
    Osinski, Kristen
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2022, 8
12345